Position in NSPR
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$7,700
-$13,490 QoQ
Shares Held
11,000
-15.4% QoQ
Ownership
0.024%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#29
of 37 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NSPR Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026Pallas Capital Advisors LLC holds $591,193,797 across 20 Medical Devices names. NSPR ranks #19 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BRKR |
Bruker Corp
|
9,483,978 | $570,745,796 | |
| 2 | ABT |
Abbott Laboratories
|
101,794 | $9,236,787 | |
| 3 | SYK |
Stryker Corp
|
18,852 | $5,935,363 | |
| 4 | TXG |
10x Genomics, Inc.
|
48,640 | $1,864,857 | |
| 5 | MDT |
Medtronic plc
|
13,872 | $1,085,206 | |
| 6 | PODD |
Insulet Corp
|
4,443 | $676,446 | |
| 7 | BSX |
Boston Scientific Corp
|
9,535 | $406,953 | |
| 8 | EW |
Edwards Lifesciences Corp
|
4,015 | $363,196 |
All Filings in NSPR
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,700 | 11,000 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $21,190 | 13,000 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $19,580 | 11,000 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $26,510 | 11,000 | Shares | Sole | 2025-11-07 | |
| No filing history on record for this holder in this stock. | ||||||